Danae M. Sharp
The University of Sydney(AU)Centenary Institute(AU)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Extracellular vesicles in disease, Cellular Mechanics and Interactions, Iron Metabolism and Disorders, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Targeting glutamine transport to suppress melanoma cell growth(2014)218 cited
- → P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration(2013)211 cited
- → Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo(2012)196 cited
- → The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action(2012)135 cited
- → Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone (Dp44mT) Overcomes Multidrug Resistance by a Novel Mechanism Involving the Hijacking of Lysosomal P-Glycoprotein (Pgp)(2015)127 cited
- → RAB27A promotes melanoma cell invasion and metastasis via regulation of pro‐invasive exosomes(2018)98 cited
- → Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells(2016)69 cited
- → HDAC inhibitors restore BRAF‐inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma(2017)57 cited
- → Abrogation of RAB27A expression transiently affects melanoma cell proliferation(2020)9 cited
- → 654 Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells(2016)4 cited